US Drug Recall Register
Class III · Low risk Terminated Initiated May 10, 2022 (4 years ago)

Xiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications.

What was recalled

Xiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-12) and b) 5- Single-Use Containers (NDC 0078-0911-05) Rx Only, Manufactured by: The Ritedose Corporation, Columbia, SC 29203, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936.

Recalling firm
Novartis Pharmaceuticals Corporation
NDC code
0078-0911-12
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0982-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all